US OptionsDetailed Quotes

VIR240816C12500

Watchlist

0.14
+0.04+40.00%

15min DelayClose Jul 22 16:00 ET

0.15High0.10Low

Vir Biotechnology Stock Discussion

Trytosaveabit

Jun 26 07:17

News

$Vir Biotechnology(VIR.US)$ Vir Biotechnology Receives FDA Ind Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

Trytosaveabit

Jun 5 04:45

Update

$Vir Biotechnology(VIR.US)$ Vir Biotechnology Announced New Preliminary Data From Phase 2 SOLSTICE Hepatitis Delta Trial, Showing Tobevibart Alone Or Combined With Elebsiran Was Generally Well Tolerated And Patients Achieved High Virologic Response And ALT Normalization

QianmengYu

May 22 13:36

need to break 12 to confirm a bottom!

$Vir Biotechnology(VIR.US)$ still too cheap!

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

QianmengYu

Apr 18 11:33

I think CFO is actually fired.

$Vir Biotechnology(VIR.US)$ They need better cost control and accounting practice to boost share price to a reasonable level (say 20). Section is bad because of Biden, but literally science is priced at 0 for VIR. Active investor should interfere. I’ll vote all Against in proxy, as I am not happy at all.

QianmengYu

Feb 22 17:26

good earnings but i don’t like

$Vir Biotechnology(VIR.US)$ small scale experiments are good.
no idea why they issue cost guidance (huge) without revenue guidance. Stupid.
I don’t like new management goes back to clinical stage biotech. They hire too many people and relocate position to high salary area. AI expert in San Francisco, come on… If not sotrovimab and help of GSK made huge money, this company would have doomed.(if not stopped by Biden, would have been 40 dollar per share). I’ll start...

Movers and Shakers

Jan 29 07:19

ColumnsToday's Morning Movers and Top Ratings: MSFT, ZI, AAL, HSY and More

Morning Movers
Gapping up
$ZoomInfo(ZI.US)$ The software stock popped 5.5% after Bank of America analyst Koji Ikeda upgraded it to buy from neutral. “We believe it is a classic self-help story that is set to outperform,” the analyst wrote, underscoring the company’s revenue growth reacceleration and new AI products as potential catalysts.
$Boeing(BA.US)$ stock rose 0.9% after Ryanair, Europe's largest airline by passenger number...

Meltyy

Jan 3 06:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

Moomoo AI

Dec 21, 2023 06:15

The multiple insider sales in Vir Biotechnology and zero buying activity in the last year may be a concern for potential investors. However, a fair level of insider ownership suggests a reasonable alignment of interests with shareholders.

Possible Bearish Signals With Vir Biotechnology Insiders Disposing Stock

Explore moomoo's "Insider Activity" for institutional sentiment

Moomoo AI

Dec 14, 2023 03:37

Adobe's stock fall and FTC probe may hit future results. Pfizer's reduced earnings projection could reshape investor outlook. Vir Biotechnology's austerity measures aim at fiscal stability. Nordson's weak Q1 forecast may impact near-term stocks.

These Stocks Are Moving the Most Today: Adobe, Apple, Pfizer, Vir Biotechnology, Costco, and More -- Barrons.com

No comment yet